A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

• Status: RECRUITING
• Trial end date: 2025-08-01

Summary

The study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.

• Phase: PHASE4

Details

• Lead Sponsor: Michelle Cardel, PhD, MS, RD